Sign In
Free Newsletter
Novo Nordisk, maker of obesity drug Wegovy, to cut 9,000 jobs to sharpen focus, meet competition
FRANKFURT, Germany (AP) — Danish pharmaceutical company Novo Nordisk, maker of weight-loss drug Wegovy, said Wednesday it would cut 9,000 jobs, 5,000 of them in Denmark, in order to strengthen the company’s focus on growth opportunities in obesity and diabetes medications. The restructuring, which would eliminate 11% of the company’s workforce, aimed to reduce organizational [&hellip[...]
Wall Street holds near its record heights
Stocks hovered near record highs Monday as investors awaited Fed Chair Jerome Powell’s speech and key earnings from Walmart, Target and Home Depot.
Pharma hub workforce training wins $3.9 million grant
The talent pipeline for the Richmond-Petersburg region’s growing advanced pharmaceutical manufacturing and biotech industries is getting a boost from a $3.9 million federal grant. Announced in mid-January, the U.S. Economic Development Administration’s Good Jobs Challenge grant was awarded to the Community College Workforce Alliance in Disputanta, a shared division of Brightpoint and [...]
Reports: Novo Nordisk in talks to buy Petersburg Ampac plant
Two South Korean media outlets have reported that the South Korean owner of Ampac Fine Chemicals may sell its manufacturing plant in Petersburg to Novo Nordisk, the Danish global pharmaceutical company. Sources told The Korea Economic Daily that the Seoul-based manufacturing conglomerate SK Group, which purchased Ampac in 2018 for a reported $576 million, is […]
